ANNALS OF SURGICAL ONCOLOGY, vol.25, no.11, pp.3141-3149, 2018 (SCI-Expanded)
The MF07-01 trial is a multicenter, phase III, randomized, controlled study comparing locoregional treatment (LRT) followed by systemic therapy (ST) with ST alone for treatment-na < ve stage IV breast cancer (BC) patients.